H.R.2562 - To amend title 39, United States Code, to allow postal patrons to contribute to funding for prostate cancer research through the voluntary purchase of certain specially issued United States postage stamps.106th Congress (1999-2000)
|Sponsor:||Rep. Cunningham, Randy (Duke) [R-CA-51] (Introduced 07/20/1999)|
|Committees:||House - Government Reform|
|Latest Action:||House - 07/26/1999 Referred to the Subcommittee on Postal Service. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Text: H.R.2562 — 106th Congress (1999-2000)All Information (Except Text)
There is one version of the bill.
Text available as:
- PDF (PDF provides a complete and accurate display of this text.) Tip?
Introduced in House (07/20/1999)
[Congressional Bills 106th Congress] [From the U.S. Government Printing Office] [H.R. 2562 Introduced in House (IH)] 106th CONGRESS 1st Session H. R. 2562 To amend title 39, United States Code, to allow postal patrons to contribute to funding for prostate cancer research through the voluntary purchase of certain specially issued United States postage stamps. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 20, 1999 Mr. Cunningham (for himself, Mr. Brown of Ohio, Mr. Weldon of Pennsylvania, Mr. Horn, Mr. Spratt, Mr. Stearns, Mr. Holden, Mr. LoBiondo, Ms. Kilpatrick, Mr. Phelps, Mr. Shows, Mr. English, Mr. McNulty, Mrs. Morella, Mr. Dixon, Mr. Foley, Mr. Cummings, Mr. Kuykendall, Mr. Faleomavaega, Mr. Calvert, Mr. Lewis of Georgia, Mr. Reyes, Mr. Rangel, Mr. Borski, and Mr. Shays) introduced the following bill; which was referred to the Committee on Government Reform _______________________________________________________________________ A BILL To amend title 39, United States Code, to allow postal patrons to contribute to funding for prostate cancer research through the voluntary purchase of certain specially issued United States postage stamps. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SPECIAL POSTAGE STAMPS TO BENEFIT PROSTATE CANCER RESEARCH. (a) In General.--Title 39, United States Code, is amended by inserting after section 414 the following: ``Sec. 414a. Special postage stamps for prostate cancer research ``(a) In order to afford the public a convenient way to contribute to funding for prostate cancer research, the Postal Service shall establish a special rate of postage for first-class mail under this section. ``(b) The rate of postage established under this section-- ``(1) shall be equal to the regular first-class rate of postage, plus a differential of not to exceed 25 percent; ``(2) shall be set by the Governors in accordance with such procedures as the Governors shall by regulation prescribe (in lieu of the procedures under chapter 36); and ``(3) shall be offered as an alternative to the regular first-class rate of postage. The use of the special rate of postage established under this section shall be voluntary on the part of postal patrons. ``(c)(1) Of the amounts becoming available for prostate cancer research pursuant to this section, the Postal Service shall pay-- ``(A) 70 percent to the National Institutes of Health; and ``(B) the remainder to the Department of Defense. Payments under this paragraph to an agency shall be made under such arrangements as the Postal Service shall by mutual agreement with such agency establish in order to carry out the purposes of this section, except that, under those arrangements, payments to such agency shall be made at least twice a year. ``(2) For purposes of this section, the term `amounts becoming available for prostate cancer research pursuant to this section' means-- ``(A) the total amounts received by the Postal Service that it would not have received but for the enactment of this section, reduced by ``(B) an amount sufficient to cover reasonable costs incurred by the Postal Service in carrying out this section, including those attributable to the printing, sale, and distribution of stamps under this section, as determined by the Postal Service under regulations that it shall prescribe. ``(d) It is the sense of the Congress that nothing in this section should-- ``(1) directly or indirectly cause a net decrease in total funds received by the National Institutes of Health, the Department of Defense, or any other agency of the Government (or any component or program thereof) below the level that would otherwise have been received but for the enactment of this section; or ``(2) affect regular first-class rates of postage or any other regular rates of postage. ``(e) Special postage stamps under this section shall be made available to the public beginning on such date as the Postal Service shall by regulation prescribe, but in no event later than 12 months after the date of the enactment of this section. ``(f) The Postmaster General shall include in each report rendered under section 2402 with respect to any period during any portion of which this section is in effect information concerning the operation of this section, except that, at a minimum, each shall include-- ``(1) the total amount described in subsection (c)(2)(A) which was received by the Postal Service during the period covered by such report; and ``(2) of the amount under paragraph (1), how much (in the aggregate and by category) was required for the purposes described in subsection (c)(2)(B). ``(g) This section shall cease to be effective at the end of the 2- year period beginning on the date on which special postage stamps under this section are first made available to the public.''. (b) Conforming Amendments.--(1) The analysis for chapter 4 of title 39, United States Code, is amended by striking the item relating to section 414 and inserting the following: ``414. Special postage stamps to benefit breast cancer research. ``414a. Special postage stamps to benefit prostate cancer research.''. (2) The heading for section 414 of title 39, United States Code, is amended to read as follows: ``Sec. 414. Special postage stamps to benefit breast cancer research.''. <all>